999 West Broadway
Suite 720
Vancouver, BC V5Z 1K5
Canada
778 331 0962
https://www.essapharma.com
Sector(s): Healthcare
Industry: Biotechnology
Full-time employees: 50
Name | Title | Pay | Exercised | Year born |
---|---|---|---|---|
Dr. David Ross Parkinson M.D. | President, CEO & Director | 814.15k | N/A | 1950 |
Mr. David S. Wood C.M.A., CPA, CMA, CPA, M.B.A., MBA | Chief Financial Officer | 590.39k | N/A | 1957 |
Mr. Peter A. Virsik M.B.A., M.S. | Executive VP & COO | 645.95k | N/A | 1971 |
Dr. Alessandra Cesano M.D., Ph.D. | Chief Medical Officer & Executive VP | 623.93k | N/A | 1961 |
Chandtip Chandhasin | Executive | N/A | N/A | N/A |
Erica Osbourne | Executive | N/A | N/A | N/A |
Erin Rudsinski | Executive | N/A | N/A | N/A |
Loleta Harris | Executive | N/A | N/A | N/A |
Neil Thapar | Executive | N/A | N/A | N/A |
Nkengyal Barber | Executive | N/A | N/A | N/A |
ESSA Pharma Inc., a clinical stage pharmaceutical company, focuses the development of small molecule drugs for the treatment of prostate cancer. The company's lead candidate EPI-7386, an androgen receptor based resistance mechanisms that develop in patients with castration-resistant prostate cancer and metastatic castration-resistant prostate cancer. It has collaboration agreements with Bayer Consumer Care AG; Janssen Research & Development, LLC; and Astellas Pharma Inc. ESSA Pharma Inc. was incorporated in 2009 and is headquartered in Vancouver, Canada.
ESSA Pharma Inc.’s ISS governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder rights: N/A; Compensation: N/A.